30
Participants
Start Date
February 28, 2018
Primary Completion Date
October 1, 2022
Study Completion Date
October 1, 2022
Nokia GO Wearable StepTracker
All participants will be provided with a Nokia GO step tracker to monitor daily step counts. The device is not subject to FDA regulation.
Medication Reminder
Medication reminders are sent to participants in Arm 2 on a daily basis.
Weekly Check-in appointment with study team or provider
Virtual meeting or telephone call between participants and study team to assess study involvement, adherence to procedures, and following of medical care recommendations.
Perelman Center for Advanced Medicine, Philadelphia
University of Pennsylvania
OTHER